发明名称 METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER
摘要 We have discovered a protein in humans, herein referred to as thymosin R16 (SEQ ID NO: 1), that is expressed in human prostate cancer tumors but not in specimens of benign prostate hyperplasma (BPH) tissues. In contrast, prostate specific antigen (PSA), the gold standard of prostate cancer diagnosis, is highly expressed in BPH tissues. Increased expression of thymosin (316 has a high correlation to disease state in a number of cancers including prostate cancer and cancers of epithelial origin. Accordingly, method of diagnosing and prognosing cancer in a patient by measuring the level of thymosin (316 in a biological test sample obtained from the patient are provided.
申请公布号 WO2004063712(A2) 申请公布日期 2004.07.29
申请号 WO2004US00447 申请日期 2004.01.09
申请人 CHILDREN'S MEDICAL CENTER CORPORATION;ZETTER, BRUCE;HUTCHINSON, LLOYD;BAO, LERE 发明人 ZETTER, BRUCE;HUTCHINSON, LLOYD;BAO, LERE
分类号 C07H21/02;C07H21/04;C12Q1/68;G01N33/574 主分类号 C07H21/02
代理机构 代理人
主权项
地址